Lv1
100 积分 2025-07-04 加入
The influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumab
9个月前
已完结
Targeted Therapy as an Alternative to Whole-Brain Radiotherapy in EGFR-Mutant or ALK-Positive Non–Small-Cell Lung Cancer With Brain Metastases
10个月前
已完结
Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data
10个月前
已完结
Combined use of radiotherapy and tyrosine kinase inhibitors in the management of metastatic non-small cell lung cancer: a literature review
10个月前
已完结
Toxicity in combination immune checkpoint inhibitor and radiation therapy: A systematic review and meta-analysis
10个月前
已完结
Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies
10个月前
已完结
AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases
10个月前
已完结
Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial
10个月前
已完结
Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
10个月前
已完结
EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases
10个月前
已完结
皖公网安备34019202002308
